Form 4: C3.ai Director Alan Murray Granted Stock Options

C3.ai Director Alan S. Murray was granted 28,628 stock options with an exercise price of $19.16, vesting over two years.

Summary

• Alan S. Murray, a Director of C3.ai, Inc. (AI), was granted 28,628 stock options.
• The options have an exercise price of $19.16 per share.
• The vesting commencement date for these options is October 3, 2025.
• The options vest at a rate of 12.5% on the last day of each fiscal quarter for two years, contingent on Murray's attendance at regularly scheduled board meetings.
• Unvested shares due to non-attendance can vest after the two-year anniversary if attendance requirements are subsequently met.
• The stock options are set to expire on October 2, 2035.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a standard compensation practice that aligns the director's interests with shareholders, indicating a commitment to long-term value creation. The vesting conditions tied to attendance are a positive governance feature.

Positives

• The grant of stock options to a director aligns management and shareholder interests, incentivizing long-term value creation.
• Vesting conditions tied to board meeting attendance promote active participation and commitment to corporate governance.

Negatives

• No specific negatives are apparent from this standard Form 4 filing, which primarily reports an insider transaction.

Risks

• The value of the stock options is inherently dependent on the future performance of C3.ai's stock price, which is subject to market fluctuations and company-specific factors.
• Failure to meet board meeting attendance requirements could result in delayed or forfeited vesting of the granted options.

Future Outlook

The grant of stock options with a ten-year expiration date suggests a long-term incentive for the director, aligning their interests with the company's future performance and strategic objectives.

Industry Context

Grants of stock options to directors are a common practice across industries, particularly in technology companies, to incentivize long-term commitment and align director interests with shareholder value creation. C3.ai, as an AI software company, uses such equity compensation to attract and retain experienced board members.

Comparison to Industry Standards

• The grant of stock options to directors is a standard compensation practice, comparable to those seen in other publicly traded technology companies like Palantir Technologies (PLTR) or Snowflake (SNOW), which frequently use equity to incentivize leadership.
• The vesting schedule, tied to board meeting attendance over two years, is a common mechanism to ensure active participation and commitment from non-executive directors, similar to governance practices at companies such as Salesforce (CRM) or Adobe (ADBE).
• An exercise price of $19.16, likely based on the market price at the time of grant, is typical for 'at-the-money' options, aligning with standard equity compensation structures.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with long-term shareholder value creation, as the options gain value only if the stock price increases.
• Board of Directors: The vesting condition tied to meeting attendance encourages active engagement and commitment from the director.

Next Steps

• Alan S. Murray will continue to serve as a Director of C3.ai, Inc.
• The stock options will vest quarterly over two years, contingent on board meeting attendance, starting October 3, 2025.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of stock options to an existing director as part of their compensation. While it aligns the director's interests with shareholders, it does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It is a standard governance and compensation disclosure.

Keywords

C3.ai, AI, Form 4, Insider Transaction, Stock Options, Director Compensation, Alan Murray, Equity Grant, Vesting Schedule